RedHawk Holdings Corp. announced today that it has entered into an agreement (the “Agreement”) with Florida -based Dolphin Medical LLC (“Dolphin”) for the exclusive distribution of RedHawk’
| LAFAYETTE, Louisiana, March 23, 2020 /PRNewswire/ -- RedHawk Holdings Corp. (OTC: SNDD) (“RedHawk” or the “Company”), a diversified holding company engaged primarily in sales and distribution of medical devices, announced today that it has entered into an agreement (the “Agreement”) with Florida-based Dolphin Medical LLC (“Dolphin”) for the exclusive distribution of RedHawk’s line of needle incineration devices (“SANDD™") for the States of Alabama, Georgia, Mississippi, Tennessee and portions of Florida (collectively “the Territories”). Under the Agreement, Dolphin has committed, among other things, to purchase annually from RedHawk for resale in the Territories, 6,000 SANDD mini™, SANDD HP™ or SANDD FR™ needle incineration devices, 2,000 SANDD Pro™ needle incineration devices and certain other medical supplies. The Agreement provides that RedHawk will sell the SANDD™ devices to Dolphin at list price less a customary distributor discount. Certain volume discounts are also available to Dolphin. Sales to Dolphin commenced in March 2020 to assist RedHawk satisfy increased product demand. About RedHawk Holdings Corp. RedHawk Holdings Corp., formerly Independence Energy Corp., is a diversified holding company which, through its subsidiaries, is engaged in the sales and distribution of medical devices, sales of branded generic pharmaceutical drugs, commercial real estate investment and leasing, sales of point of entry full-body security systems, and specialized financial services. Through its medical products business unit, the Company sells the Sharps and Needle Destruction Device (SANDD™), WoundClot Surgical - Advanced Bleeding Control, and the Carotid Artery Digital Non-Contact Thermometer. Through our United Kingdom based subsidiary, we manufacture and market branded generic pharmaceuticals. RedHawk Energy holds the exclusive U.S. manufacturing and distribution rights for the Centri Controlled Entry System, a unique, closed cabinet, nominal dose transmission full-body x-ray scanner. For more information, please visit: http://www.redhawkholdingscorp.com. Cautionary Statement Regarding Forward-Looking Statements This release may contain forward-looking statements. Forward-looking statements are all statements other than statements of historical fact. Statements contained in this release that are not historical facts may be deemed to be forward-looking statements. The words “anticipate,” “may,” “can,” “plans,” “believes,” “estimates,” “expects,” “projects,” “targets,” “intends,” “likely,” “will,” “should,” “to be,” “potential” and any similar expressions are intended to identify those assertions as forward-looking statements. Investors are cautioned that forward-looking statements are inherently uncertain. Actual performance and results may differ materially from that projected or suggested herein due to certain risks and uncertainties, including risks and uncertainties related to economic conditions and changes in market conditions. In evaluating forward-looking statements, you should consider the various factors which may cause actual results to differ materially from any forward-looking statements including those listed in the “Risk Factors” section of our latest 10-K report. Further, the Company may make changes to its business plans that could or will affect its results. Investors are cautioned that the Company will undertake no obligation to update any forward-looking statements. Company Contact: Investor Relations: Media Contact:
SOURCE RedHawk Holdings Corp. | ||
Company Codes: OTC-QB:SNDD, OTC-PINK:SNDD, OtherOTC:SNDD |
View original content:
